Skip to main content
Top
Published in: Tumor Biology 9/2016

01-09-2016 | Original Article

The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma

Authors: Yaoyong Lu, Tao Li, Ganbao Wei, Liangbo Liu, Qinsheng Chen, Lufei Xu, Kunqiang Zhang, Dehao Zeng, Rongwei Liao

Published in: Tumor Biology | Issue 9/2016

Login to get access

Abstract

Long non-coding RNAs (lncRNAs) play a critical role in cancer progression, including in nasopharyngeal carcinoma (NPC). However, it is still poorly understood whether lncRNA regulates epithelial to mesenchymal transition (EMT) and radioresistance of NPC cells. We found that lncRNA NEAT1 was significantly upregulated in NPC cell lines and tissues. Knockdown of NEAT1 could sensitize NPC cells to radiation in vitro. Further investigation found that NEAT1 regulated radioresistance by modulating EMT phenotype. Furthermore, we found that there was reciprocal repression between NEAT1 and miR-204. ZEB1 was identified as a downstream target of miR-204 and NEAT1 upregulated ZEB1 expression by negatively regulating miR-204 expression. Taking together, we proposed that NEAT1 regulated EMT phenotype and radioresistance by modulating the miR-204/ZEB1 axis in NPC.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261–70.CrossRefPubMed Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261–70.CrossRefPubMed
3.
go back to reference Teoh JW, Yunus RM, Hassan F, Ghazali N, Abidin ZA. Nasopharyngeal carcinoma in dermatomyositis patients: a 10-year retrospective review in hospital selayang, malaysia. Rep Pract Oncol Radiotherapy : J Greatpoland Cancer Center Poznan Polish Soc Radiat Oncol. 2014;19:332–6.CrossRef Teoh JW, Yunus RM, Hassan F, Ghazali N, Abidin ZA. Nasopharyngeal carcinoma in dermatomyositis patients: a 10-year retrospective review in hospital selayang, malaysia. Rep Pract Oncol Radiotherapy : J Greatpoland Cancer Center Poznan Polish Soc Radiat Oncol. 2014;19:332–6.CrossRef
4.
go back to reference Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, et al. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/MTOR pathway in prostate cancer radioresistance. Cell Death Dis. 2013;4:e875.CrossRefPubMedPubMedCentral Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, et al. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/MTOR pathway in prostate cancer radioresistance. Cell Death Dis. 2013;4:e875.CrossRefPubMedPubMedCentral
7.
go back to reference Chen LL, Zhao JC. Functional analysis of long noncoding RNAs in development and disease. Adv Exp Med Biol. 2014;825:129–58.CrossRefPubMed Chen LL, Zhao JC. Functional analysis of long noncoding RNAs in development and disease. Adv Exp Med Biol. 2014;825:129–58.CrossRefPubMed
8.
go back to reference Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun. 2014;5:5383.CrossRefPubMedPubMedCentral Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun. 2014;5:5383.CrossRefPubMedPubMedCentral
9.
go back to reference Kang J, Kim E, Kim W, Seong KM, Youn H, Kim JW, et al. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (emt) by mir-34a-mediated suppression of notch-1 expression in non-small cell lung cancer cell lines. J Biol Chem. 2013;288:27343–57.CrossRefPubMedPubMedCentral Kang J, Kim E, Kim W, Seong KM, Youn H, Kim JW, et al. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (emt) by mir-34a-mediated suppression of notch-1 expression in non-small cell lung cancer cell lines. J Biol Chem. 2013;288:27343–57.CrossRefPubMedPubMedCentral
10.
11.
go back to reference Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, et al. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014;289:12550–65.CrossRefPubMedPubMedCentral Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, et al. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014;289:12550–65.CrossRefPubMedPubMedCentral
12.
go back to reference Nakagawa S, Shimada M, Yanaka K, Mito M, Arai T, Takahashi E, et al. The lncRNA NEAT1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice. Development. 2014;141:4618–27.CrossRefPubMedPubMedCentral Nakagawa S, Shimada M, Yanaka K, Mito M, Arai T, Takahashi E, et al. The lncRNA NEAT1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice. Development. 2014;141:4618–27.CrossRefPubMedPubMedCentral
13.
go back to reference Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y, et al. Mir-124 radiosensitizes human glioma cells by targeting cdk4. J Neuro-Oncol. 2013;114:263–74.CrossRef Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y, et al. Mir-124 radiosensitizes human glioma cells by targeting cdk4. J Neuro-Oncol. 2013;114:263–74.CrossRef
15.
go back to reference Ma L, Deng X, Wu M, Zhang G, Huang J. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. FEBS Lett. 2014;588:1562–70.CrossRefPubMed Ma L, Deng X, Wu M, Zhang G, Huang J. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. FEBS Lett. 2014;588:1562–70.CrossRefPubMed
16.
go back to reference Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123:631–40.CrossRefPubMed Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123:631–40.CrossRefPubMed
17.
go back to reference Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, et al. Tumor hypoxia induces nuclear paraspeckle formation through hif-2alpha dependent transcriptional activation of neat1 leading to cancer cell survival. Oncogene. 2015;34:4546.CrossRefPubMed Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, et al. Tumor hypoxia induces nuclear paraspeckle formation through hif-2alpha dependent transcriptional activation of neat1 leading to cancer cell survival. Oncogene. 2015;34:4546.CrossRefPubMed
18.
go back to reference Li Y, Li Y, Chen W, He F, Tan Z, Zheng J, et al. Neat expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget. 2015;6:27641–50.CrossRefPubMedPubMedCentral Li Y, Li Y, Chen W, He F, Tan Z, Zheng J, et al. Neat expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget. 2015;6:27641–50.CrossRefPubMedPubMedCentral
19.
go back to reference Su H, Jin X, Zhang X, Zhao L, Lin B, Li L, et al. Fh535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line kyse-150r. J Transl Med. 2015;13:104.CrossRefPubMedPubMedCentral Su H, Jin X, Zhang X, Zhao L, Lin B, Li L, et al. Fh535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line kyse-150r. J Transl Med. 2015;13:104.CrossRefPubMedPubMedCentral
21.
go back to reference Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.CrossRefPubMedPubMedCentral Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.CrossRefPubMedPubMedCentral
22.
go back to reference Zeng J, Wei M, Shi R, Cai C, Liu X, Li T et al. Mir-204-5p/six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer. Tumour Biol : J Int Soc Oncodev Biol Med 2015. Zeng J, Wei M, Shi R, Cai C, Liu X, Li T et al. Mir-204-5p/six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer. Tumour Biol : J Int Soc Oncodev Biol Med 2015.
23.
go back to reference Zhang L, Wang X, Chen P. Mir-204 down regulates sirt1 and reverts sirt1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer. 2013;13:290.CrossRefPubMedPubMedCentral Zhang L, Wang X, Chen P. Mir-204 down regulates sirt1 and reverts sirt1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer. 2013;13:290.CrossRefPubMedPubMedCentral
24.
go back to reference Su H, Jin X, Shen L, Fang Y, Fei Z, Zhang X et al. Inhibition of cyclin d1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells. Tumour Biol : J Int Soc Oncodev Biol Med 2015. Su H, Jin X, Shen L, Fang Y, Fei Z, Zhang X et al. Inhibition of cyclin d1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells. Tumour Biol : J Int Soc Oncodev Biol Med 2015.
25.
go back to reference de Jong MC, Ten Hoeve JJ, Grenman R, Wessels LF, Kerkhoven R, Te Riele H, et al. Pretreatment microRNA expression impacting on epithelial-to-mesenchymal transition predicts intrinsic radiosensitivity in head and neck cancer cell lines and patients. Clin Cancer Res : Off J Am Assoc Cancer Res. 2015;21:5630–8.CrossRef de Jong MC, Ten Hoeve JJ, Grenman R, Wessels LF, Kerkhoven R, Te Riele H, et al. Pretreatment microRNA expression impacting on epithelial-to-mesenchymal transition predicts intrinsic radiosensitivity in head and neck cancer cell lines and patients. Clin Cancer Res : Off J Am Assoc Cancer Res. 2015;21:5630–8.CrossRef
26.
go back to reference Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, et al. Atm-mediated stabilization of zeb1 promotes DNA damage response and radioresistance through chk1. Nat Cell Biol. 2014;16:864–75.CrossRefPubMedPubMedCentral Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, et al. Atm-mediated stabilization of zeb1 promotes DNA damage response and radioresistance through chk1. Nat Cell Biol. 2014;16:864–75.CrossRefPubMedPubMedCentral
27.
go back to reference Preca BT, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, et al. A self-enforcing CD44S/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int J Cancer J int du Cancer. 2015;137:2566–77.CrossRef Preca BT, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, et al. A self-enforcing CD44S/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int J Cancer J int du Cancer. 2015;137:2566–77.CrossRef
Metadata
Title
The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma
Authors
Yaoyong Lu
Tao Li
Ganbao Wei
Liangbo Liu
Qinsheng Chen
Lufei Xu
Kunqiang Zhang
Dehao Zeng
Rongwei Liao
Publication date
01-09-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4773-4

Other articles of this Issue 9/2016

Tumor Biology 9/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine